Reliance Global Group, Inc. (NASDAQ:RELI) Q2 2023 Earnings Conference Call August 10, 2023 12:00 PM ET
Company Participants
Theodore Ayvas - Investor Relations, Crescendo Communications
Ezra Beyman - Chairman and Chief Executive Officer
Grant Barra - Senior Vice President of Operations
Moshe Fishman - Director of Insurtech and Operations
Joel Markovits - Chief Financial Officer
Conference Call Participants
Michael Albanese - EF Hutton
Operator
Greetings. Welcome to the Reliance Global Second Quarter 2023 Financial Results and Business Update Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.
I will now turn the conference over to your host, Ted Ayvas, Investor Relations. You may begin.
Theodore Ayvas
Thank you, Holly. Good afternoon and thank you for joining Reliance Global Group's 2023 second quarter financial results and business update conference call. On the call with us today are Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group; Joel Markovits, Chief Financial Officer of Reliance; Grant Barra, Senior Vice President of Operations at Reliance; and Moshe Fishman, Director of Insurtech Operations at Reliance.
Earlier today, the company announced its operating results for the three months ended June 30, 2023. The press release is posted on the company's website, www.relianceglobalgroup.com. In addition, the company has filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission today, which could also be accessed on the company's website as well as the SEC's website at www.sec.gov. If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.
Before Mr. Beyman reviews the company's operating results for the quarter ended June 30, 2023, we would like to remind everyone that this conference
- Read more current RELI analysis and news
- View all earnings call transcripts